Skip to ContentSkip to Navigation
Practical matters How to find us J.F. (Juliana F.) Vilachá Madeira R Santos


Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance

Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment

New directions in antimalarial target validation

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer

Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles

Read more